(Q45298105)

11 December 2017

title

Measurement of outcome (English)

1 reference

11 December 2017

Blazeby JM

1

1 reference

11 December 2017

publication date

1 November 2001

1 reference

11 December 2017

1 reference

11 December 2017

volume

10

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

127-133

1 reference

"Avoidable" mortality and health services: a review of aggregate data studies

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Significance of circumferential resection margin involvement after oesophagectomy for cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Surgical therapy of oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Operable esophageal cancer: current results from the West

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

A new dysphagia score with objective validation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

A Proposal for Structured Reporting of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Concurrent chemoradiation for oesophageal cancer: factors influencing myelotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Quality of quality-of-life data

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Quality of life following resection of oesophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Esophageal resection for cancer of the esophagus: long-term function and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Quality of life measurement in patients with oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Quality of Life in patients with resected oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Evaluation of quality of life in patients with malignant dysphagia.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Transmural care. A new approach in the care for terminal cancer patients: its effects on re-hospitalization and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

Cost-effectiveness in the management of patients with oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2801%2900024-X

7 January 2021

10.1016/S0960-7404(01)00024-X

Identifiers

DOI

1 reference

11 December 2017

1 reference